EPB0148 | CMV co-infection and HIV disease control among children living with HIV in Canada | E-poster | Co-infections (including opportunistic infections) |
TUPEB21 | CMV-Specific IgG changes during severe COVID-19 suggestive of acute reactivation | Poster exhibition | SARS-CoV-2, COVID-19 and HIV |
OAC0403 | Cofactors of HIV self-testing and PrEP acceptance among pregnant women at high risk of HIV in Kenya | Oral abstract session with live Q&A | HIV testing |
OAB0305 | Co-infection of High-Risk Human Papillomavirus and Human T-Lymphotropic Virus-1 among women living with HIV on Antiretroviral Therapy at a Tertiary Hospital in Kenya | Oral abstract session with live Q&A | Co-infections (including opportunistic infections) |
LBPEB03 | Combined “Test and Treat” campaigns for HIV, hepatitis B and hepatitis C: a systematic review to provide evidence to support WHO treatment guidelines | Poster exhibition | Co-infections (including opportunistic infections) |
EPD0539 | Communicating beyond psychological, social and cultural boundaries: a mental model approach towards understanding adolescent interpretation of HIV and AIDS messages | E-poster | Social science theories, concepts and methods |
EPD0678 | Communication between healthcare providers (HCPs) and high-risk young men (HRYM) in the context of stigma: views from HCPs and HRYM in Zambia | E-poster | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
EPE0897 | Community Advocacy and Partnerships in Expanding Cabotegravir Long-Acting (CAB-LA) Access: lessons for innovators, regulatory bodies, donors, and governments | E-poster | Health systems, health systems strengthening and partnerships |
EPC0504 | Community based HIV testing and treatment is feasible and yields high level of viral load suppression | E-poster | Cascades of HIV care and treatment |
OAE0203 | Community Led Monitoring (CLM): A new CLM toolkit to generate evidence to support community-led HIV service improvements | Oral abstract session with live Q&A | Innovations in data collection, monitoring and evaluation |